KLOW Stack (KPV + BPC-157 + GHK-Cu + TB-500)
Also known as KLOW · KLOW blend · KPV healing stack
New
Reconstitution & dosing guide
80 mg vial — research phases, recon steps, and a live unit calculator.
Available sizes & price
Catalog only80mg x 10 vials
KLOW(KPV 10mg+BPC 157 10mg+GHK-CU50mg+TB500 10mg) · Not in current stock
$135 / vial
Prices per vial · Research use only · Not medical advice.
Four-peptide recovery/aesthetic blend: KPV + BPC-157 + GHK-Cu + TB-500. Adds NF-κB-pathway anti-inflammatory KPV on top of the GLOW trio for deeper healing and inflammatory-control narratives.
How to picture it
KLOW takes the GLOW repair-and-remodel core (GHK-Cu, BPC-157, TB-500) and adds KPV, the inflammation mute button that quiets NF-κB noise. Picture the same structure, supply, and remodel crews — plus someone turning down the siren so repair can proceed. For research stacks where recovery and calm need to travel together, especially gut and soft-tissue contexts.
Research focus & benefits
- Repair plus anti-inflammatory blend research
- Gut and soft-tissue recovery stack interest
- NF-κB quieting layered on remodel pathways
Benefits describe research interest and pathway rationale — not guaranteed outcomes or medical advice. Research use only.
Overview
KLOW is the VERIX catalog name for a single-vial combination of KPV (10 mg), BPC-157 (10 mg), GHK-Cu (50 mg), and TB-500 (10 mg) — 80 mg total. It extends the popular GLOW aesthetic-healing stack with KPV, an α-MSH-derived tripeptide studied for gut and inflammatory modulation via NF-κB. Evidence is component-wise, not from RCTs of the tetrad.
Mechanism
Four complementary pathways: KPV dampens pro-inflammatory NF-κB signaling; BPC-157 supports angiogenic/repair and gut barrier cues; TB-500 influences actin-driven cell migration and systemic recovery; GHK-Cu drives copper-dependent matrix remodeling and gene resets associated with skin and tissue quality.
Research uses
- Component literature for each peptide
- Community multi-peptide recovery protocols
- Comparison discussions vs GLOW (3-peptide) blends
Research dosing notes
Often reconstituted and dosed as a multi-week injectable course. Sterile technique essential. Individual component research doses inform splits — not medical advice.
Half-life / kinetics
Component-dependent
Common research routes
Reported considerations
- Injection-site reactions
- Copper-related caution with high GHK-Cu
- Unknown multi-peptide interaction profile
Contraindications / cautions
- Active malignancy theoretical angiogenesis caution
- Wilson disease / copper disorders
- Pregnancy
Common research stacks
- GLOW stack
- Wolverine stack
- Oral KPV capsules
Legal / access note
Multi-peptide research blend. Not an approved drug combination.